← All Im Cannabis CORP filings

Im Cannabis CORP 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
IMCC
Im Cannabis CORP
20-F: IM Cannabis Faces Liquidity Doubts Amid German Growth, Israeli Challenges
IM Cannabis Corp. reported a slight revenue increase in 2025, driven by German market growth, but continues to face significant operating losses, liquidity concerns, and geopolitical risks in Israel.
NASDAQ
IMCC
Im Cannabis CORP
20-F: IM Cannabis Corp. Announces Financial Results and Strategic Shifts in 2024
IM Cannabis Corp. reports its 2024 financial results, highlighting a strategic focus on the German market and cost-saving measures.
NASDAQ
IMCC
Im Cannabis CORP
20-F/A: IM Cannabis Corp. Files Amendment to 20-F Annual Report Regarding Incentive Compensation Recovery Policy
IM Cannabis Corp. files an amendment to its 20-F annual report to include an Incentive Compensation Recovery Policy.
NASDAQ
IMCC
Im Cannabis CORP
20-F: IM Cannabis Corp. Navigates Challenges, Eyes Profitability in 2024 Amidst Strategic Shifts
IM Cannabis Corp. focuses on core markets and cost efficiencies, aiming for profitability in 2024 despite a revenue dip and ongoing market challenges.